At a glance
Summary
Agilent Technologies closed at 148.5 USD, keeping its weekly Trend backdrop active for a third week and leaving the stock 18.2% above its Trend Line. The Healthcare name is outperforming its sector over one and four weeks, though the latest volume read is light and the next-week expectancy state is negative at 44.02%.
- Agilent rose 1.8% in the latest week, 13.0% over four weeks and 29.4% over 12 weeks.
- The close sits 18.2% above the 125.6 USD weekly Trend Line and 15.6% above Sharemaestro Fair Value at 128.5 USD.
- Volume was 6.3M shares, only 0.6x the 13-week average of 10.9M and 0.6x the 52-week average.
- The Trend backdrop is active, but Activity Pressure shows no fresh buy signal despite a positive latest reading of 1.03.
- Risk is mixed: the stock is only 7.0% below its 52-week high, but downside weeks still outnumber upside weeks 29 to 23 over the past year.
Company analysis
The move in context
Price action: strong recovery, less support from volume
Agilent Technologies ended the week of 14 August at 148.5 USD, up 1.8%, adding to a 13.0% four-week advance and a 29.4% 12-week move. The stock now sits in the upper part of its 52-week range at 78.4%, around 7.0% below the 159.6 USD high and well above the 108.1 USD low.
The Sharemaestro read is balanced rather than outright bullish. Price is 18.2% above the weekly Trend Line at 125.6 USD and the Trend backdrop has been active for three weeks, but participation has faded. Latest volume was 6.3M shares, versus a 13-week average of 10.9M, leaving the volume ratio at 0.6x. That makes the recovery harder to confirm, even with price momentum still constructive.
Sector context: Agilent beats Healthcare, but its industry is already strong
Within US Healthcare, Agilent’s 1.8% weekly gain compares with a sector average of 0.2%, while its 13.0% four-week return is ahead of the sector’s 3.6%. The 12-week move of 29.4% is also well above Healthcare’s 9.7% average, placing the stock in a stronger part of a sector where 57.0% of names have active weekly trend signals and 75.0% show positive Market Dynamics.
The Diagnostics & Research industry gives a tougher comparison. Agilent beat the industry’s 0.8% weekly return and 8.3% four-week average, but its 29.4% 12-week return is just below the group average of 30.6%. Industry breadth is constructive on trend and activity, with 57.8% active trend signals and 80.0% positive Market Dynamics, but Relative Strength breadth is only 40.0%, showing that gains are not evenly spread across the group.
Signal state: trend active, but the signal stack is not clean
Agilent’s signal state remains constructive on price. The stock is above both the Trend Line and Sharemaestro Fair Value, and Relative Leadership has improved to 1.05 alongside Activity Pressure at 1.03. That combination supports the recent recovery and keeps the weekly regime positive.
The caveat is that Activity Pressure is classified as no fresh buy, and the composite score of 52 fits the balanced setup label. The latest readings show improvement, but not the type of broad confirmation that would remove the risk of a pause after a 29.4% quarter.
Risk and what to watch next
The main risk is that price has moved into a premium zone while volume has declined. Agilent trades 15.6% above Sharemaestro Fair Value, and 13-week weekly volatility at 5.6% is above the 52-week base of 4.7%. The one-year return profile is also uneven, with 29 downside weeks versus 23 upside weeks, although average gains of 4.4% have been larger than average losses of 2.6%.
Next week’s expectancy is negative at 44.02% based on similar historical setup states. The key watch points are whether the stock can stay above the 125.6 USD Trend Line, whether Activity Pressure continues to improve, and whether volume can rise above 1.5x average to show stronger participation in any further move toward the 52-week high.
Peer comparison
How the wider group is behaving
Breadth shows how much of the sector or industry is participating. A company move is more convincing when its peers are improving too.
US Healthcare
100 tracked companiesAbove Trend Line57.0%
Positive Relative Strength40.0%
US Diagnostics & Research
45 tracked companiesAbove Trend Line57.8%
Positive Relative Strength40.0%
Balanced view
What supports the case, and what could weaken it
What is working
- The trend backdrop is active with a 3-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
- Activity pressure is constructive, supporting the smart-money activity read.
What needs caution
- Next-week expectancy is negative at 44.02% based on similar historical setup states.
- 1 reversal markers appear in the recent smart-money tape.
Research note
This article is for educational market research only and is not financial, investment, trading, tax, or legal advice. Sharemaestro does not make buy, sell, or hold recommendations.
Source and attribution
Source: Sharemaestro. Canonical article: https://sharemaestro.com/news/agilent-fair-value-premium-thin-volume-weekly-rebound/.
Follow new Sharemaestro research through the RSS feed or JSON feed.